glp 1 court case Federal judges consolidate GLP-1 vision loss lawsuits Ozempic Lawsuit: July 2026 Blindness

In recent years, the therapeutic footprint of this class has grown: long-acting agents (e.g., liraglutide, semaglutide) and next-generation dual/triple agonists (e.g., tirzepatide) have demonstrated superior glycemic control, weight reduction, and cardiovascular benefits in adults with T2DM (Yao et al., 2024)

Staying Safe While on GLP-1 Therapy GLP-1 medications like Semaglutide and Tirzepatide offer significant benefits, especially for weight loss and blood sugar management

Semaglutide typically lowers fasting glucose and HbA1c levels by 1.01.5% in patients with type 2 diabetes through enhanced insulin secretion and reduced glucagon release

Hair loss, while its more cosmetic, can be devastating

They serve as a critical bridge between diabetes management and cardiovascular health, addressing the pressing need to mitigate cardiovascular risk in this vulnerable patient population